The lethal and enduring inequity of deceased donor liver allocation policy for hepatocellular carcinoma in the United States

American Journal of Transplantation

Volumn 13, Issue 11, 2013, Pages 2794-2796

  Charlton, M ^a  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER PATIENT; DISEASE SEVERITY; EDITORIAL; HOSPITAL ADMISSION; HUMAN; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MODEL FOR END STAGE LIVER DISEASE SCORE; ORGAN DONOR; POLICY; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; PATIENT SELECTION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84886780098     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12442     Document Type: Editorial

References (10)

1. Schuetz C, Dong N, Smoot E, et al. HCC patients suffer less from geographic differences in organ availability. Am J Transplant 2013; 13: 2989-2995.
2. Grantham D., Transforming transplantation: The effect of the health and human services final rule on the organ allocation system. San Francisco Law Rev 2001; 35: 751-782.
3. Hussong S., Administrative developments: DHHS issues organ allocation final rule. J Law Med Ethics 1999; 27: 380-382.
4. Institute of Medicine Committee on Organ Procurement and Transplantation Policy. Organ procurement and transplantation: Assessing current policies and the potential impact of the DHHS final rule, Vol. 1. Washington, DC: National Academy Press, 1999, pp. 1-38.
5. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC., A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. [See comments.] Hepatology 2000; 31: 864-871.
6. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001; 7: 567-580.
7. Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transpl 2004; 10: 36-41.
8. Sharma P, Harper AM, Hernandez JL, et al. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transplant 2006; 6: 1957-1962.
9. Goldberg D, French B, Abt P, Feng S, Cameron AM., Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl 2012; 18: 434-443.
10. Boulware LE, Troll MU, Wang NY, Powe NR., Perceived transparency and fairness of the organ allocation system and willingness to donate organs: A national study. Am J Transplant 2007; 7: 1778-1787.